Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02188901
What this trial is testing

Contrast (Sonazoid)-Enhanced US as a Screening Tool for Hepatocellular Carcinoma in Cirrhosis: An Exploratory Cross-sectional Study

Who this might be right for
Hepatocellular Carcinoma (HCC)
Yonsei University 523
Not applicableLooking for participantsNCT07010198
What this trial is testing

Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City

Who this might be right for
Hepatocellular Cancer (HCC)
Zhongshan People's Hospital, Guangdong, China 4,500
Testing effectiveness (Phase 2)Study completedNCT00554372
What this trial is testing

Recombinant Vaccinia Virus to Treat Unresectable Primary Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Jennerex Biotherapeutics 30
Testing effectiveness (Phase 2)Looking for participantsNCT05733598
What this trial is testing

Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC

Who this might be right for
Hepatocellular CarcinomaBiliary Tract Cancer
Replimune, Inc. 60
Not applicableEnded earlyNCT01005875
What this trial is testing

Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
University of Alabama at Birmingham 5
Testing effectiveness (Phase 2)Study completedNCT00003907
What this trial is testing

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Who this might be right for
Liver CancerMetastatic Cancer
Eastern Cooperative Oncology Group 50
Not applicableStudy completedNCT00679692
What this trial is testing

Evaluation the Growth Factors(IGF-1,IGFBP-3and HGH)in Patients With Chronic Liver Disease

Who this might be right for
HepatitisLiver CirrhosisHepatocellular Carcinoma
Kaohsiung Medical University Chung-Ho Memorial Hospital 210
Testing effectiveness (Phase 2)UnknownNCT00006198
What this trial is testing

Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer

Who this might be right for
Liver Cancer
National Center for Research Resources (NCRR)
Large-scale testing (Phase 3)Looking for participantsNCT06208371
What this trial is testing

Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM

Who this might be right for
Colorectal Neoplasms Malignant
Sun Yat-sen University 117
Testing effectiveness (Phase 2)Looking for participantsNCT06902389
What this trial is testing

A Clinical Study of Multi-target Hi-TCR-T Cells in the Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma (HCC)
Eastern Hepatobiliary Surgery Hospital 30
Not applicableNot Yet RecruitingNCT06836778
What this trial is testing

Comparative Study of Carvedilol Monotherapy Versus Combination Therapy With Endoscopic Variceal Ligation (EVL) for Primary Prophylaxis of Variceal Bleeding in Patients With Hepatocellular Carcinoma With High-Risk Esophageal Varices

Who this might be right for
Hepatocellular Carcinoma
Institute of Liver and Biliary Sciences, India 100
Not applicableStudy completedNCT05540925
What this trial is testing

Vascular Invasion Signatures in cfDNA Support Re-staging of Liver Cancer

Who this might be right for
Carcinoma, HepatocellularHepatocellular CancerLiver Cancer
Eastern Hepatobiliary Surgery Hospital 286
Not applicableStudy completedNCT01641276
What this trial is testing

Identification of Specific Modulation Frequencies in Hepatitis B Carriers With and Without Hepatocellular Carcinoma

Who this might be right for
HepatitisHepatocellular Carcinomas
Hospital Sirio-Libanes 60
Not applicableUnknownNCT05703750
What this trial is testing

Impact of Clinical Evident Portal Hypertension on HCC With TACE (CHANCE-CHESS 2301)

Who this might be right for
Hepatocellular CarcinomaPortal Hypertension
Zhongda Hospital 228
Not applicableUnknownNCT00553033
What this trial is testing

Laparoscopic Liver Resection

Who this might be right for
Tumors
IRCCS San Raffaele 40
Early research (Phase 1)Study completedNCT01213238
What this trial is testing

Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without Bevacizumab

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 116
Testing effectiveness (Phase 2)Study completedNCT02724540
What this trial is testing

Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver

Who this might be right for
Neuroendocrine Tumor, MalignantLiver Metastases
Abramson Cancer Center at Penn Medicine 162
Testing effectiveness (Phase 2)UnknownNCT04233840
What this trial is testing

P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
National Taiwan University Hospital 72
Testing effectiveness (Phase 2)Study completedNCT01818440
What this trial is testing

Fluoroscopy or 3-D Roadmap Imaging Software for Liver Tumor Treatment

Who this might be right for
Image-Guided Surgery
National Institutes of Health Clinical Center (CC) 28
Testing effectiveness (Phase 2)Looking for participantsNCT07246668
What this trial is testing

A Phase II Single-Arm Clinical Study to Evaluate the Efficacy and Safety of Carbon Ion Radiotherapy With Atezolizumab and Bevacizumab Combination Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver NeoplasmsCarcinoma+1 more
Yonsei University 52
Next Page